It is September 27, 2026. We flagged 242 filings this week, but the overriding theme is what happens when the music finally stops. We have an auto lender that liquidated its own inventory to survive another week, a software company that sold its software to become a pile of cash, a biotech auctioning its organs in bankruptcy court, a construction firm with a quarter-billion-dollar hole in its equity, and a fintech simply erasing its convicted ex-CEO's debt. Let us get into the wreckage.
America's Car-Mart (CRMT): The Auto Lender That Stopped Lending
America's Car-Mart secured a miserable one-week waiver extension from its lenders, pushing its deadline to October 1. You do not get a seven-day extension unless the banks are actively holding a gun to your head. The company is explicitly floating the possibility of bankruptcy, and shares predictably tanked nearly 19% on the news.
The recent Q1 FY27 print shows a business model completely paralyzed by capital starvation. Revenue plummeted 57.3% year-over-year, and retail units collapsed 82%. To scrape together immediate cash, management liquidated repossessed vehicles at wholesale, compressing gross margins to 21.8%. Unrestricted cash actually grew to $27.5 million, but inventory is down to an anemic $35.2 million. They are currently a car lender without cars or the ability to lend.
Beneficient (BENF): Erasing the Boss
Beneficient is taking a novel approach to liability management: unilaterally declaring the debt held by its former CEO as fraudulent and ripping it up. Brad Heppner was convicted of fraud in May. Now, Beneficient is looking to wipe out $130 million in debt and an $850 million preferred equity claim held by Heppner's entities, replacing the latter with a token 162,132 Class A shares.
The market loved the audacity. Wiping out hundreds of millions in liabilities because your former boss is heading to federal prison is an incredibly accretive move. Shares exploded over 300% on extreme volume after the announcement. The company wants a consensual resolution before Heppner's October 21 sentencing, presumably betting his negotiating leverage is somewhat compromised right now.
Huckleberry.ai (HUCK, formerly DOMO): A Shell and a Dream
Domo is dead; long live Huckleberry. The company completed the $400 million sale of substantially all its operating assets to Progress Software. It changed its name, and on September 24, began trading under the ticker HUCK.
What remains is a pure shell: zero debt, $221 million in cash, and over $900 million in Net Operating Losses (NOLs). That cash breaks down to roughly $4.46 per share. Founder Josh James is still running the entity, stating they are evaluating opportunities. The stock is trading around $3.45, meaning the market is valuing the cash at 77 cents on the dollar—a steep discount that suggests investors are deeply skeptical of how James plans to spend that war chest.
Sangamo Therapeutics (SGMOQ): Selling the Organs
Sangamo is effectively liquidating in Chapter 11. The company completed the sale of its Fabry disease gene therapy (ST-920) to PTC Therapeutics. PTC outbid the original stalking horse, Astellas, at the bankruptcy auction, paying $111 million in cash plus up to $100 million in milestones. Eli Lilly also showed up to buy Sangamo's zinc finger and capsid delivery platforms for $50 million.
The estate is harvesting over $163 million in cash, but common stockholders are structurally subordinate to creditors. The stock officially delisted to the OTC markets today as SGMOQ. Management explicitly warned that trading in the shares is highly speculative, which is bankruptcy lawyer speak for assuring you that your equity is a zero.
Southland Holdings (SLND): Digging a Hole
Southland Holdings caught a delisting warning from NYSE American. The company is sitting on a staggering $248.2 million stockholders' deficit and has a strict October 23 deadline to submit a plan to regain compliance.
With a Price-to-Sales ratio of 0.06, the market has entirely given up on the quality of Southland's revenues. Traditional earnings metrics are useless here due to deep trailing-twelve-month losses and negative free cash flow. A prominent 13F fund recently trimmed its position, and it is hard to blame them. A quarter-billion-dollar hole in the equity is not something you fix with a compliance plan; you fix it with a miracle.
What to Watch
Keep your eyes on the October 1 deadline for America's Car-Mart. A one-week waiver is the financial equivalent of holding your breath. If they do not announce a highly dilutive recapitalization or a fire sale by Thursday, expect a Chapter 11 filing before the weekend.